Literature DB >> 24508466

miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2.

Zhiqiang Wang1, Qiao Qiao2, Min Chen3, Xianhua Li1, Zhenjun Wang1, Chuanxin Liu1, Zongtao Xie4.   

Abstract

miR-625 has been reported to exhibit abnormal expression in esophageal cancer (EC), but the mechanism and functions of miR-625 in esophageal cancer remain unclear. miR-625 down-regulation and Sox2 up-regulation were validated by qRT-PCR in 158 EC samples. Low expression of miR-625 promotes cell proliferation and invasion, while high expression of miR-625 has the opposite effect. Sox2, a target gene of miR-625, was examined by luciferase assay and western blot. Our data suggest that miR-625 may regulate the biological processes of EC via controlling Sox2 expression.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Invasion; Proliferation; Sox2; miR-625

Mesh:

Substances:

Year:  2014        PMID: 24508466     DOI: 10.1016/j.febslet.2014.01.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  The decreased expression of miR-625 predicts poor prognosis of esophageal squamous cell carcinoma.

Authors:  Chuan Li; Da-Cheng Li; Shu-Sheng Che; Kai Ma; Yong-Jie Wang; Li-Hong Xia; Xiao-Mei Dai; Gang-Ting Zhang; Yi Shen; Wen-Jie Jiao; Kai-Hua Tian
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

3.  Expression of microRNA 638 and sex-determining region Y-box 2 in hepatocellular carcinoma: Association between clinicopathological features and prognosis.

Authors:  Weikang Ye; Jieke Li; Guan Fang; Xiupeng Cai; Yan Zhang; Chaojun Zhou; Lei Chen; Wenjun Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

4.  miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.

Authors:  Yurong Sun; Xiuwen Yu; Qingyang Bai
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  LINC00852 Regulates Cell Proliferation, Invasion, Migration and Apoptosis in Hepatocellular Carcinoma Via the miR-625/E2F1 Axis.

Authors:  Shi Chen
Journal:  Cell Mol Bioeng       Date:  2021-12-03       Impact factor: 2.321

6.  Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.

Authors:  Ren Zhang; Xiaonan Chen; Shengjie Zhang; Xueyan Zhang; Tong Li; Zhicai Liu; Jinwu Wang; Wenqiao Zang; Yuanyuan Wang; Yuwen Du; Guoqiang Zhao
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

7.  Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells.

Authors:  Saffiyeh Saboor-Maleki; Fatemeh B Rassouli; Maryam M Matin; Mehrdad Iranshahi
Journal:  Technol Cancer Res Treat       Date:  2016-05-20

Review 8.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

9.  Long non-coding RNA small nucleolar RNA host gene 7 facilitates the proliferation, migration, and invasion of esophageal cancer cells by regulating microRNA-625.

Authors:  Yuan Wang; Dengke Bao; Lixin Wan; Chenghui Zhang; Shuang Hui; Hongqiang Guo
Journal:  J Gastrointest Oncol       Date:  2021-04

10.  Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.

Authors:  Ying Shao; Peng Li; Sheng-tao Zhu; Ji-ping Yue; Xiao-jun Ji; Zhen He; Dan Ma; Li Wang; Yong-jun Wang; Ye Zong; Yong-dong Wu; Shu-tian Zhang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.